We are grateful for the interest of Professors Hadziselimovic, Emmons and Snyder (Hadziselimovic et al., 2008) for our paper on hormone levels in normal boys and boys with cryptorchidism or hypospadias (Pierik et al., 2008). They point out a controversy between our above mentioned paper and an earlier paper of Dr De Muinck Keizer-Schrama et al. (1988) in which HPT hormones were measured in another group of cryptorchid boys and in controls. In the latter study, no significant difference between the testosterone levels in the two groups was detected, whereas in our more recent study a significant difference was found. Prof Hadziselimovic and co-authors enquire: ''What changed in the last 20 years?''. We would like to point out that the population-based selection of boys in our recent study was different from the hospital-based design in the previous study. The boys in our recent study were aged between 35 and 184 days (mean: 80 days) at the time of blood collection. This contrasts with the group reported earlier in which samples were collected from the cryptorchid boys between 80 and 420 days-of-age. In the earlier paper, it is stated ''the sign test revealed no significant differences in the three groups (controls, and boys with persistent or transient cryptorchidism) from the age of 80 to 180 days''. We now stated that ''the lower testosterone in the cryptorchid boys was mainly due to a higher proportion of testosterone levels below the detection limit among boys that were 100 or more days old, suggesting that in cryptorchidism cases the androgen nadir may be reached more rapidly''. Because the levels of hypothalamus-pituitary-testis axis hormones change dramatically in the first 6 months of life, we adjusted for the 'time since birth' in the latter study, applying statistical techniques that were not available in 1988. As we adjusted for the country of origin, we do not think that the increase of the Turkish population in Rotterdam during the last 20 years plays an important role. As described in the paper, we reached identical conclusions when the statistics was applied to the subjects of Dutch origin only. Finally, we already stated that we did not have data on the severity of the cryptorchidism in all cases. In conclusion, the differences in population characteristics (e.g. the age distribution) and in the statistical techniques used are likely to explain the difference between the results of the two studies as far as the question asked is concerned. We do not see how the histology of the testes could be of help in deciding if testosterone levels in control and cryptorchid boys are different.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.